» Articles » PMID: 33808235

Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Apr 3
PMID 33808235
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Biocompatible nanoparticles (NPs) containing polymers, lipids (liposomes and micelles), dendrimers, ferritin, carbon nanotubes, quantum dots, ceramic, magnetic materials, and gold/silver have contributed to imaging diagnosis and targeted cancer therapy. However, only some NP drugs, including Doxil (liposome-encapsulated doxorubicin), Abraxane (albumin-bound paclitaxel), and Oncaspar (PEG-Asparaginase), have emerged on the pharmaceutical market to date. By contrast, several phytochemicals that were found to be effective in cultured cancer cells and animal studies have not shown significant efficacy in humans due to poor bioavailability and absorption, rapid clearance, resistance, and toxicity. Research to overcome these drawbacks by using phytochemical NPs remains in the early stages of clinical translation. Thus, in the current review, we discuss the progress in nanotechnology, research milestones, the molecular mechanisms of phytochemicals encapsulated in NPs, and clinical implications. Several challenges that must be overcome and future research perspectives are also described.

Citing Articles

A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections.

Rahimian M, Jafari-Gharabaghlou D, Mohammadi E, Zarghami N Phage (New Rochelle). 2025; 5(4):203-222.

PMID: 40045937 PMC: 11876824. DOI: 10.1089/phage.2024.0011.


Exploring the anti-inflammatory activities, mechanism of action and prospective drug delivery systems of tocotrienol to target neurodegenerative diseases.

Mathew A, Bhuvanendran S, Nair R, Radhakrishnan A F1000Res. 2024; 12:338.

PMID: 39291146 PMC: 11406131. DOI: 10.12688/f1000research.131863.1.


: a review in the context of PPPM approach.

Xu W, Yang T, Zhang J, Li H, Guo M EPMA J. 2024; 15(2):233-259.

PMID: 38841616 PMC: 11147995. DOI: 10.1007/s13167-024-00367-3.


Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine.

Liu Z, Lu T, Qian R, Wang Z, Qi R, Zhang Z Int J Nanomedicine. 2024; 19:2507-2528.

PMID: 38495752 PMC: 10944250. DOI: 10.2147/IJN.S455407.


The Potential Use of Vitamin D3 and Phytochemicals for Their Anti-Ageing Effects.

Santa K, Kumazawa Y, Watanabe K, Nagaoka I Int J Mol Sci. 2024; 25(4).

PMID: 38396804 PMC: 10889119. DOI: 10.3390/ijms25042125.


References
1.
Jeevanandam J, Barhoum A, Chan Y, Dufresne A, Danquah M . Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018; 9:1050-1074. PMC: 5905289. DOI: 10.3762/bjnano.9.98. View

2.
Mohtashami L, Ghows N, Tayarani-Najaran Z, Iranshahi M . Galbanic Acid-Coated Fe3O4 Magnetic Nanoparticles with Enhanced Cytotoxicity to Prostate Cancer Cells. Planta Med. 2018; 85(2):169-178. DOI: 10.1055/a-0721-1886. View

3.
Chen B, Dai W, He B, Zhang H, Wang X, Wang Y . Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment. Theranostics. 2017; 7(3):538-558. PMC: 5327631. DOI: 10.7150/thno.16684. View

4.
Fang L, Chen B, Liu S, Wang R, Hu S, Xia G . Synergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells. Int J Nanomedicine. 2012; 7:4109-18. PMC: 3415324. DOI: 10.2147/IJN.S32475. View

5.
Chaudhary A, Jaswal V, Choudhary S, Sonika , Sharma A, Beniwal V . Ferulic Acid: A Promising Therapeutic Phytochemical and Recent Patents Advances. Recent Pat Inflamm Allergy Drug Discov. 2019; 13(2):115-123. DOI: 10.2174/1872213X13666190621125048. View